How to buy Avecho Biotechnology (AVE) shares

Learn how to easily invest in Avecho Biotechnology shares.

Avecho Biotechnology Limited
+ A$0.0020 ( + 11.76%)

We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!

Avecho Biotechnology Limited is a biotechnology business based in Australia. Avecho Biotechnology shares (AVE) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Avecho Biotechnology has a trailing 12-month revenue of around $453,536. If you're looking to buy shares, check out the steps below.

How to buy shares in Avecho Biotechnology

  1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
  3. Search for Avecho Biotechnology. Find the share by name or ticker symbol: AVE. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Avecho Biotechnology reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
  6. Check in on your investment. Congratulations, you own a part of Avecho Biotechnology. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Avecho Biotechnology stock price (ASX:AVE)

Use our graph to track the performance of AVE stocks over time.

Avecho Biotechnology shares at a glance

Information last updated 2021-09-17.
52-week range$0.007 - $0.038
50-day moving average $0.0171
200-day moving average $0.0187
Target price$1.72
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.002

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Name Product Standard brokerage fee Inactivity fee Markets
Superhero share trading
AUD $5
ASX shares, US shares
Australia’s lowest-cost broker for ASX shares and ETFs.
Pay zero brokerage on US stocks and all ETFs and just $5 (flat fee) to trade Australian shares from your mobile or desktop.
IG Share Trading
AUD $8 or 0.1%
$50 per quarter if you make fewer than three trades in that period
ASX shares, Global shares
$0 brokerage for US and global shares plus get an active trader discount of $5 commission on Australian shares.
Enjoy some of the lowest brokerage fees on the market when trading Australian shares, international shares, plus get access to 24-hour customer support.
Saxo Capital Markets (Classic account)
AUD $5
ASX shares, Global shares, Forex, CFDs, Margin trading, Options trading, ETFs
Access 19,000+ stocks on 40+ exchanges worldwide
Low fees for Australian and global share trading, no inactivity fees, low currency conversion fee and optimised for mobile.
ThinkMarkets Share Trading
AUD $8
ASX shares
Limited-time offer: Get 10 free ASX trades ($0 brokerage) when you open a share trading account with ThinkMarkets(T&Cs apply).$8 flat fee brokerage for CHESS Sponsored ASX stocks (HIN ownership), plus free live stock price data on an easy to use mobile app.
HSBC Online Share Trading
AUD $19.95
ASX shares, mFunds, ETFs, Bonds
Limited time offer: Get up to $100 in brokerage rebates on your first 5 trades when you sign up to a HSBC Online Share Trading account (T&Cs apply). Make trades online with brokerage fees starting from just $19.95 with an HSBC Online Share Trading account. Plus gain access to complimentary expert research, trading ideas and tools.
Bell Direct Share Trading
AUD $15
ASX shares, mFunds, ETFs
Invest in Australian shares, options and managed funds from the one account with no inactivity fee.
Bell Direct offers a one-second placement guarantee on market-to-limit ASX orders or your trade is free, plus enjoy extensive free research reports from top financial experts.
CMC Markets Invest
AUD $11 or 0.1%
ASX shares, Global shares, mFunds, ETFs
$0 brokerage on global shares including US, UK and Japan markets.
Trade up to 9,000 products, including shares, ETFs and managed funds, plus access up to 15 major global and Australian stock exchanges.

Compare up to 4 providers

Is it a good time to buy Avecho Biotechnology stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Avecho Biotechnology price performance over time

Historical closes compared with the last close of A$0.019

1 week (2021-09-09) 18.75%
1 month (2021-08-18) 11.76%
3 months (2021-06-18) 5.56%
6 months (2021-03-19) -13.64%
1 year (2020-09-18) 137.50%
2 years (2019-09-18) 280.00%
3 years (2018-09-18) -20.83%
5 years (2016-09-16) -18.80%

Is Avecho Biotechnology under- or over-valued?

Valuing Avecho Biotechnology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avecho Biotechnology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Avecho Biotechnology's EBITDA

Avecho Biotechnology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 million (£592,494).

The EBITDA is a measure of a Avecho Biotechnology's overall financial performance and is widely used to measure a its profitability.

Avecho Biotechnology financials

Revenue TTM $453,536
Gross profit TTM $240,912
Return on assets TTM -46.27%
Return on equity TTM -70.29%
Profit margin 0%
Book value 0.003
Market capitalisation $34.9 million

TTM: trailing 12 months

Avecho Biotechnology share dividends

We're not expecting Avecho Biotechnology to pay a dividend over the next 12 months.

Have Avecho Biotechnology's shares ever split?

Avecho Biotechnology's shares were split on 22 April 1999.

Avecho Biotechnology share price volatility

Over the last 12 months, Avecho Biotechnology's shares have ranged in value from as little as $0.007 up to $0.038. A popular way to gauge a stock's volatility is its "beta".

AVE.AU volatility(beta: 2.07)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Avecho Biotechnology's is 2.0707. This would suggest that Avecho Biotechnology's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Avecho Biotechnology overview

Avecho Biotechnology Limited, a biotechnology company, develops, produces, sells, and licenses products using its patented platform technology, Targeted Penetration Matrix (TPM) drug delivery system for the pharmaceutical, animal health, and nutrition industries in Australia and internationally. The company operates through Production, Human Health, and Other segments. It offers TPM and Vital ET products for use in drug delivery and cosmetic formulations; and develops TPM/Oxymorphone and TPM/Oxycodone. The company's human health portfolio covers delivery of pharmaceutical products through gels, injectables, and patches. It provides non-antibiotic feed additive products to enhance feed efficiency and the health of livestock animals. The company was formerly known as Phosphagenics Limited and changed its name to Avecho Biotechnology Limited in May 2019. Avecho Biotechnology Limited was incorporated in 1992 is based in Clayton, Australia.

Avecho Biotechnology in the news

There are no recent company news

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder only provides general advice and factual information, so consider your own circumstances, or seek advice before you decide to act on our content. By submitting a question, you're accepting our Terms of Use, Disclaimer & Privacy Policy and Privacy & Cookies Policy.
Go to site